Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 32 studies | 35% ± 17% | |
| fibroblast | 32 studies | 34% ± 16% | |
| pericyte | 21 studies | 35% ± 20% | |
| astrocyte | 19 studies | 56% ± 17% | |
| smooth muscle cell | 17 studies | 36% ± 13% | |
| oligodendrocyte precursor cell | 16 studies | 68% ± 21% | |
| endothelial cell of lymphatic vessel | 15 studies | 39% ± 19% | |
| ciliated cell | 15 studies | 35% ± 19% | |
| oligodendrocyte | 15 studies | 33% ± 12% | |
| macrophage | 14 studies | 31% ± 14% | |
| microglial cell | 13 studies | 36% ± 16% | |
| glutamatergic neuron | 12 studies | 55% ± 24% | |
| GABAergic neuron | 11 studies | 67% ± 22% | |
| vein endothelial cell | 10 studies | 29% ± 19% | |
| mast cell | 10 studies | 34% ± 7% | |
| epithelial cell | 9 studies | 39% ± 20% | |
| adipocyte | 9 studies | 58% ± 18% | |
| B cell | 7 studies | 26% ± 10% | |
| connective tissue cell | 7 studies | 27% ± 8% | |
| myofibroblast cell | 7 studies | 39% ± 16% | |
| amacrine cell | 7 studies | 48% ± 17% | |
| abnormal cell | 6 studies | 27% ± 17% | |
| neuron | 6 studies | 57% ± 19% | |
| interneuron | 6 studies | 72% ± 19% | |
| retinal ganglion cell | 6 studies | 43% ± 21% | |
| myeloid cell | 6 studies | 32% ± 8% | |
| retina horizontal cell | 6 studies | 34% ± 14% | |
| retinal cone cell | 6 studies | 46% ± 13% | |
| monocyte | 6 studies | 33% ± 11% | |
| dendritic cell | 6 studies | 31% ± 8% | |
| mesothelial cell | 6 studies | 33% ± 14% | |
| Mueller cell | 6 studies | 58% ± 25% | |
| type I pneumocyte | 6 studies | 35% ± 11% | |
| type II pneumocyte | 6 studies | 40% ± 12% | |
| retinal bipolar neuron | 5 studies | 50% ± 20% | |
| capillary endothelial cell | 5 studies | 26% ± 7% | |
| cardiac muscle cell | 5 studies | 43% ± 7% | |
| retinal rod cell | 5 studies | 40% ± 12% | |
| T cell | 5 studies | 30% ± 8% | |
| club cell | 5 studies | 32% ± 13% | |
| basal cell | 5 studies | 33% ± 19% | |
| mononuclear phagocyte | 4 studies | 23% ± 5% | |
| conventional dendritic cell | 4 studies | 24% ± 3% | |
| granule cell | 4 studies | 59% ± 10% | |
| progenitor cell | 4 studies | 38% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 3% | |
| retinal pigment epithelial cell | 4 studies | 60% ± 20% | |
| lymphocyte | 4 studies | 34% ± 7% | |
| OFF-bipolar cell | 4 studies | 50% ± 25% | |
| ON-bipolar cell | 4 studies | 50% ± 26% | |
| naive B cell | 4 studies | 16% ± 1% | |
| endothelial cell of vascular tree | 4 studies | 36% ± 16% | |
| leukocyte | 4 studies | 24% ± 7% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 53% ± 2% | |
| GABAergic interneuron | 3 studies | 71% ± 4% | |
| glial cell | 3 studies | 32% ± 7% | |
| plasma cell | 3 studies | 27% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
| GABAergic amacrine cell | 3 studies | 61% ± 9% | |
| glycinergic amacrine cell | 3 studies | 51% ± 3% | |
| rod bipolar cell | 3 studies | 63% ± 18% | |
| memory B cell | 3 studies | 17% ± 1% | |
| hepatocyte | 3 studies | 60% ± 21% | |
| ependymal cell | 3 studies | 72% ± 10% | |
| enteroendocrine cell | 3 studies | 33% ± 12% | |
| adventitial cell | 3 studies | 41% ± 20% | |
| alveolar macrophage | 3 studies | 45% ± 12% | |
| natural killer cell | 3 studies | 24% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 0% | |
| muscle cell | 3 studies | 62% ± 18% | |
| goblet cell | 3 studies | 24% ± 7% | |
| transit amplifying cell | 3 studies | 43% ± 29% | |
| mucus secreting cell | 3 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 99% | 3129.27 | 1433 / 1445 | 100% | 11.34 | 183 / 183 |
| brain | 97% | 2801.46 | 2567 / 2642 | 99% | 18.16 | 700 / 705 |
| thymus | 100% | 3022.87 | 652 / 653 | 96% | 8.05 | 582 / 605 |
| breast | 100% | 4728.19 | 459 / 459 | 95% | 8.82 | 1065 / 1118 |
| lung | 99% | 3229.41 | 574 / 578 | 95% | 7.29 | 1102 / 1155 |
| skin | 100% | 5735.58 | 1809 / 1809 | 94% | 13.86 | 442 / 472 |
| intestine | 100% | 3895.45 | 964 / 966 | 93% | 5.58 | 491 / 527 |
| stomach | 99% | 2647.18 | 354 / 359 | 93% | 7.82 | 266 / 286 |
| uterus | 100% | 11048.38 | 170 / 170 | 91% | 7.03 | 417 / 459 |
| adrenal gland | 100% | 2458.62 | 258 / 258 | 90% | 5.93 | 208 / 230 |
| prostate | 100% | 2953.02 | 244 / 245 | 90% | 6.32 | 454 / 502 |
| pancreas | 96% | 1386.79 | 315 / 328 | 93% | 6.14 | 165 / 178 |
| bladder | 100% | 4394.24 | 21 / 21 | 84% | 4.80 | 424 / 504 |
| ovary | 100% | 2441.99 | 180 / 180 | 83% | 4.23 | 356 / 430 |
| kidney | 90% | 1350.35 | 80 / 89 | 90% | 6.72 | 809 / 901 |
| liver | 85% | 822.00 | 191 / 226 | 57% | 2.23 | 232 / 406 |
| blood vessel | 100% | 3197.33 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 5724.64 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3669.79 | 802 / 803 | 0% | 0 | 0 / 0 |
| spleen | 99% | 1425.56 | 239 / 241 | 0% | 0 | 0 / 0 |
| heart | 93% | 1610.63 | 800 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 86% | 8.17 | 69 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 5.97 | 38 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 3.54 | 20 / 29 |
| peripheral blood | 29% | 961.90 | 267 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000724 | Biological process | double-strand break repair via homologous recombination |
| GO_0042276 | Biological process | error-prone translesion synthesis |
| GO_0006261 | Biological process | DNA-templated DNA replication |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016035 | Cellular component | zeta DNA polymerase complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0051539 | Molecular function | 4 iron, 4 sulfur cluster binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0000166 | Molecular function | nucleotide binding |
| Gene name | REV3L |
| Protein name | REV3 like, DNA directed polymerase zeta catalytic subunit REV3-like, catalytic subunit of DNA polymerase zeta (Yeast) DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3) |
| Synonyms | POLZ REV3 |
| Description | FUNCTION: Catalytic subunit of the DNA polymerase zeta complex, an error-prone polymerase specialized in translesion DNA synthesis (TLS). Lacks an intrinsic 3'-5' exonuclease activity and thus has no proofreading function. . |
| Accessions | C4TNX2 H0Y5T4 F2Z3A1 C4TNX0 C4TNX1 ENST00000368802.8 [O60673-1] ENST00000413831.1 ENST00000435970.5 [O60673-2] ENST00000434009.5 C4B7Q4 ENST00000358835.7 [O60673-1] ENST00000422377.5 O60673 |